The assessment of TIMP-1 and other direct markers of fibrosis in serum, which has been validated as the enhanced liver fibrosis (ELF) test, is used in patients with non-alcoholic fatty liver disease (NAFLD). The gene discussed is TIMP1; the disease is Hepatic fibrosis.